
On March 10, 2026, the European Data Protection Board (EDPB) and the European Data Protection Supervisor (EDPS) issued a joint opinion on the European Commission’s proposed EU Biotech Act - a forthcoming legislative framework expected to materially affect how clinical trials are designed, conducted, and governed in the EU. The proposal, introduced in December 2025, would amend key EU life sciences legislation, including the EU Clinical Trials Regulation (CTR), and introduce new requirements … [Read more] about EU Privacy Regulators Weigh in on the Proposed EU Biotech Act: Key Takeaways for Life Sciences Companies



